See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Coherus BioSciences, Inc. (CHRS) - free report >>
Kamada Ltd. (KMDA) - free report >>
Neuronetics, Inc. (STIM) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Coherus BioSciences, Inc. (CHRS) - free report >>
Kamada Ltd. (KMDA) - free report >>
Neuronetics, Inc. (STIM) - free report >>
Image: Shutterstock
New Strong Sell Stocks for August 25th
Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:
Beam Global (BEEM - Free Report) is a cleantech company, designs, develops, engineers, manufactures, and sells renewably energized products. The Zacks Consensus Estimate for its current year earnings has been revised 73.3% downward over the last 30 days.
Coherus BioSciences, Inc. (CHRS - Free Report) is a biopharmaceutical company that focuses on the biosimilar and immuno-oncology market. The Zacks Consensus Estimate for its current year earnings has been revised nearly 21% downward over the last 30 days.
Kamada Ltd. develops, produces, and markets plasma-derived protein therapeutics for orphan indications. The Zacks Consensus Estimate for its current year earnings has been revised 35.3% downward over the last 30 days.
Neuronetics, Inc. (STIM - Free Report) is a commercial stage medical technology company. The Zacks Consensus Estimate for its current year earnings has been revised 24.2% downward over the last 30 days.
Phunware, Inc. (PHUN - Free Report) provides integrated software platform. The Zacks Consensus Estimate for its current year earnings has been revised 32.1% downward over the last 30 days.
View the entire Zacks Rank #5 List.